Vivus says drug delayed progression to diabetes

By weight-loss - Yahoo! News Search Results   //   Weight-loss News  //  Comments Off on Vivus says drug delayed progression to diabetes
Drugmaker Vivus said patients who took its weight loss drug Qsymia were more than 70 percent less likely to develop type 2 diabetes compared to patients who took a placebo. The data comes from a group ...

Comments are closed.